The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy: Two-Year Follow-Up Results
Open accessAbstract
Background —Previous studies have shown disappointing results for immunosuppressive treatment in patients with dilated cardiomyopathy. Therefore, we studied the effectiveness of such therapy in patients with HLA upregulation on biopsy. Methods and Results —Of 202 patients with dilated cardiomyopathy, 84 patients with increased HLA expression were randomized to receive either immunosuppression or placebo for 3 months; they were then followed for 2 years. After 2 years, there were no significant differences in the primary end point (a composite of death, heart transplantation, and hospital readmission) between the 2 study groups (22.8% for the immunosuppression group and 20.5% for the placebo). The secondary efficacy end point included changes in ejection fraction, end-diastolic diameter, end-diastolic volume, end-systolic volume and NYHA class; left ventricular ejection fraction increased significantly in the immunosuppression group compared with the placebo group (95% CI, 4.20 to 13.12; P <0.001) after 3 months of follow-up. The early favorable effects of immunosuppressive therapy on left ventricular volume, left ventricular diastolic dimension, and New York Heart Association class were also present. This improvement was maintained in the immunosuppression group at 2 years (ejection fraction: 95% CI, 6.94 to 19.04; P <0.001). In addition, on the basis of the protocol-specified definition of improvement, 71.8% patients in the immunosuppression group versus 20.9% patients in the placebo group met the criteria of improvement after 3 months ( P <0.001). At the end of the follow-up period, 71.4% patients from the immunosuppression group versus 30.8% patients from the placebo group were improved ( P =0.001). Conclusions —These data demonstrate a long-term benefit of immunosuppressive therapy in patients with dilated cardiomyopathy and HLA upregulation on biopsy specimens. Thus, restoration of immunosuppressive therapy for such patients should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Circulation · doi:10.1161/01.cir.93.5.841 · Cited by 3,458 · cited 1×
“(1) An intention-to-treat analysis with the 2-tailed Fisher’s exact test included all randomized patients (except patients who withdrew) for all follow-up end points.”
MethodA Clinical Trial of Immunosuppressive Therapy for Myocarditis
Mason, J. W., O'Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330501 · Cited by 1,274
Idiopathic Dilated Cardiomyopathy
Dec, G. W., & Fuster, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412083312307 · Cited by 963
Feldman, A. M., & McNamara, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431908 · Cited by 958
Myocarditis: The Dallas criteria
Thomas Aretz, H. (1987) · Human Pathology · doi:10.1016/s0046-8177(87)80363-5 · Cited by 809
Kawai, C. (1999) · Circulation · doi:10.1161/01.cir.99.8.1091 · Cited by 552
Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis
Chow, L. H., Radio, S. J., Sears, T. D., & Mcmanus, B. M. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90465-8 · Cited by 355
A Prospective, Randomized, Controlled Trial of Prednisone for Dilated Cardiomyopathy
Parrillo, J. E., Cunnion, R. E., Epstein, S. E., Parker, M. M., Suffredini, A. F., Brenner, M., Schaer, G. L., Palmeri, S. T., Cannon, R. O., Alling, D., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910193211601 · Cited by 353
Magnusson, Y., Wallukat, G., Waagstein, F., Hjalmarson, A., & Hoebeke, J. (1994) · Circulation · doi:10.1161/01.cir.89.6.2760 · Cited by 347
Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy
Caforio, A. L. P., Bonifacio, E., Stewart, J. T., Neglia, D., Parodi, O., Bottazzo, G. F., & Mckenna, W. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)92821-i · Cited by 205
Cited by
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
Cooper, L. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0800028 · Cited by 1,318
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00435-x · Cited by 1,217
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.186093 · Cited by 1,030
Kindermann, I., Barth, C., Mahfoud, F., Ukena, C., Lenski, M., Yilmaz, A., Klingel, K., Kandolf, R., Sechtem, U., Cooper, L. T., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.074 · Cited by 919
Bozkurt, B., Colvin, M., Cook, J., Cooper, L. T., Deswal, A., Fonarow, G. C., Francis, G. S., Lenihan, D., Lewis, E. F., McNamara, D. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000455 · Cited by 891
Sagar, S., Liu, P. P., & Cooper, L. T. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60648-x · Cited by 743
van Heerebeek, L., Hamdani, N., Handoko, M. L., Falcao-Pires, I., Musters, R. J., Kupreishvili, K., Ijsselmuiden, A. J. J., Schalkwijk, C. G., Bronzwaer, J. G. F., Diamant, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.728550 · Cited by 723
Chronic Heart Failure and Inflammation: What Do We Really Know?
Dick, S. A., & Epelman, S. (2016) · Circulation Research · doi:10.1161/circresaha.116.308030 · Cited by 692
Predictors of Outcome in Patients With Suspected Myocarditis
Kindermann, I., Kindermann, M., Kandolf, R., Klingel, K., Bültmann, B., Müller, T., Lindinger, A., & Böhm, M. (2008) · Circulation · doi:10.1161/circulationaha.108.769489 · Cited by 683
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.008 · Cited by 672
Viral myocarditis—diagnosis, treatment options, and current controversies
Pollack, A., Kontorovich, A. R., Fuster, V., & Dec, G. W. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.108 · Cited by 657
Weintraub, R. G., Semsarian, C., & Macdonald, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31713-5 · Cited by 649
Kociol, R. D., Cooper, L. T., Fang, J. C., Moslehi, J. J., Pang, P. S., Sabe, M. A., Shah, R. V., Sims, D. B., Thiene, G., Vardeny, O., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000745 · Cited by 625
Myocarditis: Current Trends in Diagnosis and Treatment
Magnani, J. W., & Dec, G. W. (2006) · Circulation · doi:10.1161/circulationaha.105.584532 · Cited by 610
Frustaci, A., Russo, M. A., & Chimenti, C. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp249 · Cited by 604
Diagnosis of Myocarditis: Death of Dallas Criteria
Baughman, K. L. (2006) · Circulation · doi:10.1161/circulationaha.105.589663 · Cited by 546
Jefferies, J. L., & Towbin, J. A. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62023-7 · Cited by 535
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 521
Caforio, A. L. P., Calabrese, F., Angelini, A., Tona, F., Vinci, A., Bottaro, S., Ramondo, A., Carturan, E., Iliceto, S., Thiene, G., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm076 · Cited by 484
Mechanisms of Autoantibody-Induced Pathology
Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00603 · Cited by 469
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm456 · Cited by 464
Frustaci, A., Chimenti, C., Calabrese, F., Pieroni, M., Thiene, G., & Maseri, A. (2003) · Circulation · doi:10.1161/01.cir.0000048147.15962.31 · Cited by 462
Ammirati, E., Cipriani, M., Moro, C., Raineri, C., Pini, D., Sormani, P., Mantovani, R., Varrenti, M., Pedrotti, P., Conca, C., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035319 · Cited by 452
Fung, G., Luo, H., Qiu, Y., Yang, D., & McManus, B. (2016) · Circulation Research · doi:10.1161/circresaha.115.306573 · Cited by 444
Yilmaz, A., Kindermann, I., Kindermann, M., Mahfoud, F., Ukena, C., Athanasiadis, A., Hill, S., Mahrholdt, H., Voehringer, M., Schieber, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.924167 · Cited by 431
Dennert, R., Crijns, H. J., & Heymans, S. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn296 · Cited by 411
Daubeney, P. E. F., Nugent, A. W., Chondros, P., Carlin, J. B., Colan, S. D., Cheung, M., Davis, A. M., Chow, C. W., & Weintraub, R. G. (2006) · Circulation · doi:10.1161/circulationaha.106.635128 · Cited by 382
Blauwet, L. A., & Cooper, L. T. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.11.006 · Cited by 374
Jaeggi, E. T., Fouron, J.-C., Silverman, E. D., Ryan, G., Smallhorn, J., & Hornberger, L. K. (2004) · Circulation · doi:10.1161/01.cir.0000142046.58632.3a · Cited by 367
The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy
Heymans, S., Eriksson, U., Lehtonen, J., & Cooper, L. T. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.937 · Cited by 359
Schultheiss, H.-P., Kuhl, U., & Cooper, L. T. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr165 · Cited by 301
Inflammatory Cardiomyopathic Syndromes
Trachtenberg, B. H., & Hare, J. M. (2017) · Circulation Research · doi:10.1161/circresaha.117.310221 · Cited by 289
Management of Myocarditis-Related Cardiomyopathy in Adults
Tschöpe, C., Cooper, L. T., Torre-Amione, G., & Van Linthout, S. (2019) · Circulation Research · doi:10.1161/circresaha.118.313578 · Cited by 279
Caforio, A. L. P., Mahon, N. J., Tona, F., & McKenna, W. J. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00010-7 · Cited by 273
Diagnosis and Treatment of Myocarditis in Children in the Current Era
Canter, C. E., & Simpson, K. E. (2014) · Circulation · doi:10.1161/circulationaha.113.001372 · Cited by 259
Holzmann, M., Nicko, A., Kühl, U., Noutsias, M., Poller, W., Hoffmann, W., Morguet, A., Witzenbichler, B., Tschöpe, C., Schultheiss, H.-P., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.743427 · Cited by 258
Seferović, P. M., Tsutsui, H., McNamara, D. M., Ristić, A. D., Basso, C., Bozkurt, B., Cooper, L. T., Filippatos, G., Ide, T., Inomata, T., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2190 · Cited by 219
Myocarditis in Humans and in Experimental Animal Models
Błyszczuk, P. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00064 · Cited by 161
Corticosteroids for Viral Myocarditis
Chen, H. S., Wang, W., Wu, S., & Liu, J. P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004471.pub3 · Cited by 158
Myocarditis: Infection Versus Autoimmunity
Rose, N. R. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9339-z · Cited by 127
Suzuki, J.-I., Ogawa, M., Futamatsu, H., Kosuge, H., Sagesaka, Y. M., & Isobe, M. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.05.007 · Cited by 77
Fulminant myocarditis proven by early biopsy and outcomes
Huang, F., Ammirati, E., Ponnaiah, M., Montero, S., Raimbault, V., Abrams, D., Lebreton, G., Pellegrino, V., Ihle, J., Bottiroli, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad707 · Cited by 69
Peretto, G., Sala, S., De Luca, G., Marcolongo, R., Campochiaro, C., Sartorelli, S., Tresoldi, M., Foppoli, L., Palmisano, A., Esposito, A., et al. (2020) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2020.05.013 · Cited by 56
Caforio, A. L. P., Angelini, A., Blank, M., Shani, A., Kivity, S., Goddard, G., Doria, A., Schiavo, A., Testolina, M., Bottaro, S., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.10.165 · Cited by 53
Efficacy of immunosuppressive therapy in myocarditis: A 30-year systematic review and meta analysis
Cheng, C.-Y., Cheng, G.-Y., Shan, Z.-G., Baritussio, A., Lorenzoni, G., Tyminska, A., Ozieranski, K., Iliceto, S., Marcolongo, R., Gregori, D., et al. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102710 · Cited by 41
Uccello, G., Bonacchi, G., Rossi, V. A., Montrasio, G., & Beltrami, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010150 · Cited by 33
“Close collaboration between cardiologists and other specialists should be promoted to identify cardiac involvement promptly and define therapeutic strategies and prognostication.”
BackgroundJain, A., Bruno, K. A., Matsumori, A., Cooper, L. T., Yamani, M., & Fairweather, D. (2022) · Comprehensive Pharmacology · doi:10.1016/b978-0-12-820472-6.00091-8 · Cited by 1
Metadata
- Authors
- Wojnicz, R., Nowalany-Kozielska, E., Wojciechowska, C., Glanowska, G., Wilczewski, P., Niklewski, T., Zembala, M., Poloński, L., Rozek, M. M., & Wodniecki, J.
- Venue
- Circulation
- Published
- 2001-07-03
- Volume
- 104
- Issue
- 1
- Pages
- 39-45
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2111652408
- Cited by
- 459
- References
- 27
- FWCI
- 11.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.